Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

7.37
-0.4000-5.15%
Pre-market: 7.15-0.2200-2.99%07:30 EDT
Volume:1.01M
Turnover:7.56M
Market Cap:453.11M
PE:-1.12
High:7.68
Open:7.68
Low:7.35
Close:7.77
Loading ...

BUZZ-Sage Therapeutics soars after Biogen makes $441.7 mln bid for company

Reuters
·
11 Jan

Biogen Inc Reports 10.2% Stake in Sage Therapeutics Inc as of Jan 10, 2025

THOMSON REUTERS
·
11 Jan

Biogen Inc - Submits Non-Binding Proposal to Buy All Outstanding Shares of Sage Therapeutics' Common Stock Not Owned by Biogen for $7.22/Share in Cash

THOMSON REUTERS
·
11 Jan

Biogen Inc Says on January 10, Delivered Letter to Sage Therapeutics' CEO - SEC Filing

THOMSON REUTERS
·
11 Jan

RBC Raises Price Target on SAGE Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
07 Jan

Wall Street Analysts Believe Sage Therapeutics (SAGE) Could Rally 42.02%: Here's is How to Trade

Zacks
·
06 Jan

Sage Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
03 Jan

Sage Therapeutics price target lowered to $9 from $26 at Piper Sandler

TIPRANKS
·
02 Jan

Sage Therapeutics (SAGE) Surges 12.2%: Is This an Indication of Further Gains?

Zacks
·
23 Dec 2024

Sage Therapeutics price target lowered to $6 from $10 at Stifel

TipRanks
·
17 Dec 2024

Sage Therapeutics Is Maintained at Hold by Stifel

Dow Jones
·
16 Dec 2024

Sage Therapeutics Inc : Mizuho Cuts Target Price to $6 From $10

THOMSON REUTERS
·
12 Dec 2024

Mizuho Securities Sticks to Their Hold Rating for SAGE Therapeutics (SAGE)

TIPRANKS
·
12 Dec 2024

Biogen Stock Declines 21.4% in 3 Months: How to Play the Stock

Zacks
·
10 Dec 2024

ADVISORY-Alert wrongly tagged to Sage Therapeutics withdrawn

Reuters
·
05 Dec 2024

Sage Secures $35 Million in Series B Funding to Transform Senior Living Operations Across the U.S. and Beyond

THOMSON REUTERS
·
05 Dec 2024

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)

TIPRANKS
·
25 Nov 2024

Sage Therapeutics Drug's Failure in Huntington's 'Not Surprising,' RBC Says

MT Newswires Live
·
22 Nov 2024

Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More

Zacks
·
22 Nov 2024

Sage Therapeutics Is Maintained at Hold by TD Cowen

Dow Jones
·
22 Nov 2024